Moolec Science SA Logo

Moolec Science SA

Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.

MLEC | NDAQ

Overview

Corporate Details

ISIN(s):
LU2559000059 (+1 more)
LEI:
Country:
United States of America
Address:
17, BOULEVARD F.W. RAIFFEISAN, LUXEMBOURG
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Moolec Science SA is a science-based ingredient company that utilizes a proprietary Molecular Farming technology to produce animal proteins and other valuable nutritional ingredients in plants. By introducing animal genes into the genomes of crops like soybeans and safflower, the company uses plants as bioreactors to create sustainable and scalable food ingredients. Its key products include bioengineered soybeans containing porcine proteins (Piggy Sooy™) and safflower oil with a high concentration of gamma-linolenic acid (GLASO™). Moolec aims to provide cost-effective, traceable, and functional ingredients for the food, animal feed, and dietary supplement industries, offering an alternative to traditional animal-based production systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Moolec Science SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Moolec Science SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Moolec Science SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America IBIO
Ibotta, Inc. Logo
A performance marketing platform offering cash-back rewards to consumers from CPG brands.
United States of America IBTA
ICON PLC Logo
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America ICLR
IDEAYA Biosciences, Inc. Logo
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
United States of America IDYA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
IMMERSION CORP Logo
Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.
United States of America IMMR
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America IMUX

Talk to a Data Expert

Have a question? We'll get back to you promptly.